GENE ONLINE|News &
Opinion
Blog

Policy
Outlining the Future of Vaccine Business: Industry, Investment, and Public Health
2021-06-21
From Great Challenges to Great Opportunities: An Outlook on US-China Biotech Relationships
2021-06-18
M&A
Amidst Battle with FTC, Illumina Faces Scrutiny from EU Over its $7.1B GRAIL Merger
2021-04-20
Quad Members Join Forces to Produce 1 Billion Vaccines for Indo-Pacific Countries
2021-03-16
China Approves Avastin’s New Indication
2020-09-25
Part I Highlights of BIO Asia-Taiwan 2020 (Day 1): The Effect of COVID-19 on Global Biotech Industry
2020-07-22Partner
With NASH Drug Rejected, Intercept CEO Lambasts FDA’s Evolving Guidelines
2020-07-01
BIO Digital 2020 Highlights: Challenges in Bringing New Cell and Gene Therapies to Market
2020-06-23
India’s First Homemade COVID-19 PCR Kit Commercially Approved by Government
2020-03-24
First Potential Treatment for COVID-19 Greenlighted by Korean Authorities
2020-03-08
Crowdsourcing, a Novel Data Sharing Strategy to Augment Patient Care: Interview with Dr. Alireza Haghighi at Harvard Medical School
2019-09-10
Live Report – 2018 BioJapan: Witness Japan’s biotechnology industry development policy and the innovation of pharmaceutical industry
2018-10-11
Taiwan Approves Six Cell Therapies Under Revised Guidelines
2018-09-13
Guidance for cell therapy in Taiwan will be released in September
2018-08-09
FDA Released Draft Guidance for Pregnant Women in Clinical Trials
2018-04-19
LATEST
10x Genomics Eyes Regional Opportunities in Asia-Pacific, Launches First Overseas Manufacturing Hub
2021-10-26
Shaping the Future of the Beauty Industry: Can Skin Microbiome Products Succeed Cosmetics?
2021-10-25
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Daiichi Sankyo to Launch mRNA Covid-19 Vaccine in 2022, Shionogi Presents Clinical Results of Covid-19 Oral Drug
2021-10-22
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!